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Abstract The Göttingen minipig model of obesity is used in
pre-clinical research to predict clinical outcome of new treat-
ments for metabolic diseases. However, treatment effects of-
ten remain unnoticed when using single parameter statistical
comparisons due to the small numbers of animals giving rise
to large variation and insufficient statistical power. The pur-
pose of this study was to perform a correlation matrix analysis
of multiple multi-scale parameters describing co-segregation
of traits in order to identify differences between lean and obese
minipigs. More than 40 parameters, ranging from physical,
cardiovascular, inflammatory and metabolic markers were
measured in lean and obese animals. Correlation matrix anal-
ysis was performed using permutation test and bootstrapping
at different levels of significance. Single parameter com-
parisons yielded significant differences between lean and
obese animals mainly for known physical traits. On the
other hand, functional network analysis revealed new co-
segregations, particularly in the domain of inflammatory
and oxidative stress markers in the obese animals that
were not present in the lean. Functional networks of lean
or obese minipigs could be utilised to assess drug effects
and predict changes in parameters with a certain degree of
precision, on the basis of the networks confidence inter-
vals. Comparison of functional networks in minipigs with
those of human clinical data may be used to identify
common parameters or co-segregations related to obesity
between animal models and man.
Keywords Functional network analysis . animalmodels .
obesity . correlationmatrix . Göttingenminipig
Introduction
Translation of the effect of novel therapeutics from animal
models of obesity to the corresponding human condition is a
major challenge in drug development. A number of animal
models are available that mimic various aspects of human
obesity. These animal models display varying face, construct
and predictive validity and will therefore typically reveal only
some of the molecular targets involved in human disease
development [5, 18]. They may partially mimic clinical signs
and aetiology of the human condition [9], and they may
display gene expression, metabolomics or proteomics that
only to some extent are comparable to those found in humans.
Among others, obese Göttingen minipigs constitute an
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excellent large animal model as they share many characteris-
tics of obesity with the clinical human situation. For example,
they can obtain an overweight of more than 100 % and a body
fat percentage of around 40–50 %, which is more than what is
seen in diet induced rodent models and comparable to what is
seen in obese humans [8, 19]. Furthermore, studies with
Göttingen minipigs fed with a high-fat diet indicate that they
develop early pre-diabetic changes similar to those found in
humans [2, 12]. However, qualified selection of parameters to
measure and their individual power in predicting clinical
efficacy or safety remain a major challenge in pre-clinical
drug development. Also, in view of the relatively small num-
ber of non-rodents typically used in research for ethical,
economical or housing reasons, proper validation of efficacy
markers used for novel drug candidates is extremely
important.
Pharmacotherapy is aimed at normalising deviations in
clinical biomarkers and risk factors that have been demon-
strated to relate to obesity and its comorbidities. Therefore, to
assess efficacy of novel therapeutics in animal models of
disease, such clinical parameters should preferentially behave
in a similar manner as in humans in order to increase the
predictive power of results obtained in animal experiments
to the clinical situation. It is becoming more and more evident
that conventional single parameter comparisons between
groups do not provide sufficient predictive validity of a model,
and that multi-parameter comparisons may improve the un-
derstanding of the disease process and therapeutic potential of
drug candidates [4].
The purpose of this study was to evaluate co-
segregation of multiple phenotypical traits using correla-
tion matrix analysis in order to create patterns of traits
characterising the lean vs. the obese state, respectively.
Network analysis is commonly used in systems biology
in which interactions or relations are investigated on a
molecular basis, between proteins, in pathway analysis or
gene expression patterns. A comparable approach, but on
a higher level of organisation, i.e. network analysis of
functional physiological or phenotypical traits was de-
scribed previously, showing promising results [17, 23].
Multiple parameters or traits were measured ranging
from anatomical and physical, cardiovascular, metabolic
and inflammatory markers, which are all considered to
reflect key processes in the aetiology of obesity and
associated comorbidities. This study showed that single
parameter comparisons yielded few significant differ-
ences between lean and obese animals. However, when
subjected to correlation matrix analysis, several impor-
tant differences were revealed between lean and obese
animals, notably within oxidative stress and inflammatory
processes. This method may provide improved insight in
translational aspects of disease processes between animal
models and humans.
Material and methods
Göttingen minipigs
Animals were treated in accordance with the Animal Experi-
mentation Act of Denmark, which is in accordance with the
Council of Europe Convention ETS 123. The study was
approved by the Danish National Animal Experimentation
Board.
Seven ovariectomized (OVX) diet-induced obese and sev-
en lean OVX Göttingen minipigs were used (age 3–4 years,
Ellegaard Göttingen Minipigs A/S, Dalmose, Denmark). The
minipigs were housed at the Copenhagen University animal
research facilities (Taastrup, Denmark) and were fed standard
minipig chow (Minipig Maintenance, Altromin, Christian
Petersen A/S, Gentofte, Denmark). The lean group was fed
restrictively 150 g twice a day whilst the obese group was fed
ad libitum. The obese pigs had previously been used in
pharmacological studies with therapeutic peptides, but had
been subjected to wash-out periods exceeding multiple half-
lives of these drugs prior to this study.
Phenotypic characterization of the pigs
Body weight (BW) was obtained by weighing the pigs on an
ordinary large animal scale on the day of euthanasia. Body
composition was determined in connection with flow mediat-
ed dilatation (FMD) measurements by use of dual energy X-
ray absorptiometry scanning (DEXA) (Hologic Explorer,
Santax Medico, Aarhus, Denmark). The DEXA scanning
was performed on anaesthetized pigs (intramuscular injection
of midazolam 1 mg/kg and ketamine 5 mg/kg) in ventral
recumbency with the front and hind limbs stretched back-
wards. The analysis of body composition was performed
using the scanner software package, which estimates the mass
of the scanned individual (MASS) and calculates the absolute
mass of each tissue (bone; BMC, lean tissue; NONFATand fat
tissue; FAT) in relation to this estimate.
Blood sampling Blood was sampled by venepuncture of the
jugular vein in appropriate containers (citrate, EGTA, etc.)
from fasted animals (12–18 h) under light sedation with
appropriate doses of Zoletil (Tiletamine/zolazepam, Virbac
Danmark A/S, Denmark) for later analysis of oxidative stress,
inflammatory and metabolic markers. Serum and plasma was
collected immediately after centrifugation and stored at −80 or
−20 °C until further analysis. Details of each analysis are
described below.
Flow mediated vasodilation (FMD) image acquisition, anal-
ysis and calculation Pigs were fasted 12–18 h prior to the
FMD examination within 4 weeks before euthanasia. Pigs
were anaesthetized and a protocol similar to that described
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previously was followed [15]. An ultrasound unit with a
13 MHz linear array transducer was used to acquire 2-D
ultrasonographic images of the right brachial artery. Continu-
ous 2-D image recording of all phases of the cardiac cycle for
off-line automated edge detection and luminal diameter mea-
surement were performed at defined time periods with con-
stant settings so that a constant number of frames were re-
corded for all pigs. Pulsed-wave spectral Doppler ultrasonog-
raphy was used to record blood flow in the brachial artery. The
mean angle correction used was 69°±3.5°. For each pig, 2-D
longitudinal ultrasonographic images of the artery were ob-
tained during a 30 s period, followed by a 10 s recording of
arterial blood flow velocity waveforms obtained via pulsed-
wave Doppler ultrasonography before cuff inflation. For in-
duction of reactive hyperaemia, the brachial artery was oc-
cluded for 5 min by inflating a blood pressure cuff above
250 mm Hg. An additional 10 s of spectral Doppler ultraso-
nographic blood flow velocity waveforms was recorded im-
mediately following cuff deflation, and no later than 15 s
following cuff deflation, 2-D longitudinal ultrasonographic
images of the artery were obtained sequentially during the
following 2-minute period. Approximately 8–10 min follow-
ing cuff deflation, a new 2-D longitudinal baseline recording
was obtained during a 30 s period. Nitroglycerine (0.4 mg/
dose) was then applied sublingually to evaluate endothelium-
independent vasodilatation to exogenous nitric oxide (NO)
and immediately hereafter, a 2-D longitudinal recording was
performed during the following 2 min. Data were analysed
off-line using commercially available software and FMD and
flow velocity integral (FVI delta) were calculated as described
previously [15].
Biomarkers of oxidative stress and acute phase inflammatory
response Plasma biopterins (BH2, BH4) were analyzed by
HPLC with coulometric and fluorescence detection as de-
scribed previously [16]. Total vitamin C (VitC) and Plasma
Ascorbate (Asc) were analyzed by HPLC with coulometric
detection following reduction of endogenous dehydroascorbic
acid (DHA) using tris[2-carboxyethyl]phosphine hydrochlo-
ride as described elsewhere [14]. DHA was expressed as a
percentage of total VitC. Serum concentrations of Haptoglo-
bin (Hp), C-reactive protein (CRP), serum amyloid A (SAA)
and Pig α1-acid glycoprotein (PAGP) were measured as pre-
viously described [10, 11, 20]. After blood sampling, the
animals were euthanized by an intravenous overdose of pen-
tobarbital (150 mg/kg) (Pentobarbital 200 mg/ml, Glostrup
Pharmacy, Denmark) and necropsy was performed.
Coronary artery function and structure The ventral side of the
left ventricle of the heart was quickly excised shortly after
euthanasia. The tissue was positioned using pins in a petri dish
with a Sylgard® bottom, continuously bathed with freshly
oxygenated Krebs’s solution (95 % O2/5 % CO2/25 mM
HCO3
−), and viewed under a stereo microscope (Leica M80,
LeicaMicrosystems, Heerbrugg, Switzerland) using cold light
illumination (Leica CLS 150XE). The proximal 3–4 cm of the
main left coronary artery (LCA) from the opening into the
aorta was removed quickly using blunt dissection and trans-
ferred to fixative for histological examination. The proximal
part (3–4 cm) of the left anterior descending artery (LAD) was
carefully removed by blunt dissection and transferred to cold
oxygenated Krebs’s solution and used for isometric wire
myograph experiments. Using a pair of sharpened tweezers
and ophthalmic scissors, 2nd and 3rd order side branches of
the remaining distal LAD were gently dissected free from
surrounding ventricular muscle and transferred to cold oxy-
genated Krebs’s solution for vessel dimension analyses.
Dimension analysis Second and third order LAD segments
were transferred to the bath of a pressure myograph (120CP,
DMT A/S, Aarhus, Denmark), mounted between two glass
pipettes and slowly heated to 37 ° C while the intraluminal
pressure was gently raised in stepwise increments to 100 mm
Hg. The myograph was placed on the stage of an inverted
microscope (Olympus IX71), and the pressurized arteries
were viewed at low magnification (4×) through the glass
bottom of the bath. A CCD camera connected to Myoview
software (both DMT A/S) was used for simultaneous mea-
surement of lumen and external diameters of a 1-2 mm seg-
ment of the pressurized artery. Before recording of the diam-
eters, arteries were superfused for 30 min with freshly oxy-
genated Ca2+-free Krebs’s solution (including 2 mM EGTA)
to which the L-type Ca2+ channel blocker nifedipine (5 μM)
was added. This ensured complete relaxation of the arteries in
order to obtain the passive structural dimensions of each artery
(vessel lumen diameter, wall thickness (Wall Th), and
wall/lumen ratio (W/L)).
Coronary artery functional analysis Proximal LAD speci-
mens were cut into segments of about 2–4 mm in length and
mounted on two stainless steel pins in a wire myograph
(610 M, DMTA/S, Aarhus, Denmark). Optimal lumen diam-
eters (Do) and maximal potassium stimulated contractions (K
+
max) were identified following a normalization procedure, as
previously described [21]. Sensitivities for nifedipine (pD2
NIF), substance P (pD2 SP) and bradykinin (pD2, BRAD)
(all obtained from Sigma-Aldrich) were assessed by logistic
regression of cumulative concentration response curves con-
structed on top of 1 μM U46619-induced pre-contractions
(U46619 max) using Prism 5.0 (GraphPad Software, La Jolla,
CA, USA).
Histopathology of the left coronary artery (LCA) After
48 hours in 4 % formalin, the proximal LCA samples were
processed conventionally and embedded in paraffin. Samples
were cut into 2–4 μm serial cross-sections for routine
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histology (Hematoxylin and Eosin staining (HE)). A semi-
quantitative scoring system was used to evaluate intimal
thickening (0=none; 1=mild; 2=moderate; 3=severe) on
HE stained sections. Evaluation of samples was done in a
blinded fashion.
Metabolic parameters For glucose measurements, 10 μL of
plasma was transferred into 500 μL EBIO solution and mea-
sured on a Biosen auto analyzer (BIOSEN S_Line, EKF Diag-
nostics, Cardiff, UK) according to the manufacturer’s instruc-
tions. Pig insulin content in plasma was measured using lumi-
nescence oxygen channeling immunoassay (LOCI), which is a
homogenous bead-based assay, as previously described [3].
Fructosamine (FRUC), triglycerides (TG), total cholesterol
(CHOL), high density lipoprotein cholesterol (HDL) and low
density lipoprotein cholesterol (LDL) were measured on a
Cobas® 6000 (Roche Diagnostics GmbH, Mannheim, Ger-
many) according to the manufacturer’s instructions.
Correlation matrix of traits and statistical analysis A corre-
lation matrix for all measured traits was calculated for both the
lean and obese groups followed by permutation test or
bootstrapping in order to identify the probability of having a
true correlation at four different levels of significance
(p<0.001, p<0.005, p<0.01 and p<0.05) using a customized
Matlab script (Mathworks, Natick, MA, USA) based on a
script kindly provided by G. A. Churchill [17]. A normality
test was performed for each trait. Functional network visual-
isation was done using Gephi software (The Gephi Consor-
tium, Paris, France). Single trait comparisons between groups
were performed using Student’s unpaired t test (two-tailed) or
by non-parametric comparison (Mann–Whitney) depending
on normality of parameter distribution.
Results
Comparison of all measured traits between lean and obese
animals was performed in two different ways. Firstly, in a
conventional manner by finding statistically significant differ-
ences of parameters between groups using two-sided t test
analyses, in which differences between groups were consid-
ered significant for p<0.05. As the purpose of this study was
to compare single comparisons to functional network analysis,
the t test was used to obtain as many potential significant
outcomes as possible although the risk of type 1 error is
evident. The results of these comparisons are summarized in
Table 1. Non-parametric test (Mann–Whitney) gave the same
results as t test with regard to significance of differences
between traits. Secondly, by constructing a correlation matrix
of all traits, followed by a permutation test or bootstrapping in
order to find statistically significant co-segregations of traits.
Phenotypic characterization of the animals At the time of
euthanasia, the obese minipigs weighed about twice as much
as the lean and their fat and lean mass were significantly
increased or decreased, respectively, both in absolute and
relative terms (Table 1).
Apart from obvious differences in physical characteristics
between lean and obese animals, there were remarkably few
statistical differences in metabolic parameters, i.e. lipid profile
and plasma glucose were not different between lean and
obese. Surprisingly, plasma insulin was lower and hence,
QUICKI index was significantly higher in the obese (Table 1).
When comparing biomarkers of oxidative stress and inflam-
mation on an individual basis, no differences were observed
between obese and lean animals (Table 1). Main LAD diam-
eter was significantly increased in the obese, in line with an
increased heart weight in these animals. However, artery
diameter in the obese did not increase proportionally with
HW, since absolute diameter per gram heart tissue was signif-
icantly lower in the obese as compared to the lean (6.81±
0.27 μm/g (n=15) vs. 6.04±0.16 μm/g (n=18) in lean and
obese, respectively). Likewise, an apparent cardiac hypertro-
phy was observed in the obese, yet, when corrected for BW,
HW per kg BW was lower in the obese as compared to lean
animals (3.06±0.10 g/kg vs. 2.44±0.12 g/kg in lean and
obese, respectively). Contractility, as evidenced by maximum
response to high K+ and U46619, was slightly decreased in
obese left coronary arteries. Sensitivity to the dihydropyridine
L-type calcium channel blocker nifedipine was higher, where-
as that to substance P was lower, in coronary arteries of the
obese, compared to those of lean minipigs (Table 1). Dimen-
sions (Lumen, WTh, W/L ratio) of second order coronary
arteries were not different between lean and obese. There
was no clear evidence of impaired in vivo endothelial func-
tion. Absolute responses (FVI delta, FMD and FMD nitro) in
obese were significantly higher than those in lean animals, but
not when expressed in relative terms (Table 1).
Histopathology of the LCA One pig from the obese group was
excluded due to problems during tissue preparation. No dif-
ferences were found in the degree of intimal thickening be-
tween the lean and the obese pigs (p>0.05). Mild to moderate
intimal thickening with foamy macrophages was present in
both groups (5 of 7 lean animals and in all obese animals)
while severe intimal thickening was seen in two pigs from the
lean group.
Correlation Matrix analysis The strength of correlations be-
tween traits was initially evaluated using permutation test
(10,000 permutations of every pair of traits). A summary of
co-segregation of traits for different levels of significance
following permutation is given in Table 2. However, due to
missing values for some traits, the total number of observa-
tions per trait was in some cases only 5 or 6, instead of 7, as
Pflugers Arch - Eur J Physiol
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Table 1 A summary of averaged
results (mean values±standard
error of the mean) for all traits in
lean and obese Göttingen
minipigs
All numbers are based on seven
observations, except when indi-
cated otherwise by the numbers
between brackets
a denotes statistical significance of
differences (p <0.05) between
groups as determined by Student
t test
Traits Lean Obese
• Physical traits
Body weight (BW, kg) 50.3±1.6 92.6±5.2 a
Mass (MASS, kg) 49.5±1.5 86.7±4.9 a
Non-fat mass (NONFAT, kg) 35.3±0.7 49.2±2.7 a
Fat mass (FAT, kg) 12.9±1.0 36.4±2.7 a
Bone mineral content (BMC, kg)) 1.22±0.05 1.08±0.04a
Non-fat mass fraction (NONFAT %) 74.0±1.4 58.1±1.6 a
Fat mass fraction (FAT %) 26.0±1.4 41.9±1.6 a
Heart weight (HW, g) 155.2±5.0 219.3±14.0 a
• Metabolic factors
Fasting plasma glucose (GLUC, mM) 3.80±0.09 3.74±0.36
Fasting plasma insulin (INS, pM) 141.2±32.4 39.16±9.89 a
QUICKI 0.38±0.01 0.50±0.03 a
C-Peptide (pM) 152.5±21.0 72.75±18.09 (6) a
Plasma total cholesterol (CHOL, mM) 1.77±0.11 (6) 1.98±0.10
Plasma triglyceride (TG, mM) 0.28±0.04 (6) 0.46±0.07
Plasma low density lipoprotein (LDL, mM) 0.67±0.05 (6) 0.85±0.10
Plasma high density lipoprotein (HDL, mM) 1.11±0.06 (6) 1.05±0.05
Plasma fructosamine (FRUC, μM) 262.0±7.9 (6) 236.1±9.8
• Biomarkers of oxidative stress and inflammation
Plasma dihydrobiopterin (BH2, nM) 3.0±0.1 3.4±0.4
Plasma tetrahydrobiopterin (BH4, nM) 19.6±1.8 18.7±1.7
BH2/BH4 0.16±0.02 0.20±0.05
Plasma total ascorbic acid (VitC, μM) 29.5±2.7 33.0±2.0
Plasma ascorbate (Asc, μM) 25.2±2.9 30.3±2.6
Percentage dehydroascorbic acid (%DHA of total VitC) 15.2±2.6 8.8±2.9
(PAGP, μg/mL) 242.6±35.3 229.2±34.0
Haptoglobin (Hp, μg/mL) 2594±484 3115±625
C-reactive protein (CRP, μg/mL) 0.63±0.15 0.51±0.16
Serum amyloid A protein (SAA, μg/mL) 11.0±2.2 18.5±6.9
• Coronary artery traits
2nd order coronary artery lumen diameter (lumen, μm) 420.2±61.3 (6) 409±51.9 (5)
2nd order coronary artery wall thickness (WTh, μm) 53.5±5.6 (6) 62.0±8.8 (5)
Wall/lumen ratio (W/L) 0.15±0.04 (6) 0.17±0.04 (5)
Left coronary artery optimal diameter (Do, μM) 1034±83 (6) 1314±70 (6)
a
Left coronary artery K+ max response (Kmax, N/m) 21.2±3.2 (6) 19.6±1.5 (6)
U46619 max response (U64619, N/m) 15.9±2.6 (6) 12.8±2.4 (6)
Nifedipine sensitivity (PD2 NIF, −Log(IC50)) 8.44±0.23 (6) 9.06±0.09 (6) a
Substance P sensitivity (PD2 SP, −Log(IC50)) 11.02±0.21 (5) 9.96±0.09 (6) a
Bradykinin sensitivity (PD2 BRAD, −Log(IC50)) 7.41±0.35 (5) 7.47±0.19 (5)
• In vivo peripheral vascular function
FVI delta (m/s) 105.4±58.3 (5) 343.5±36.6 (6) a
FVI, Δ (%) 113.5±68.6 (5) 556.3±192.6 (6)
Absolute change in luminal diameter (FMD, mm) 0.18±0.05 (6) 0.36±0.05 (6) a
FMD, % 9.1±3.1 (6) 12.9±1.8 (6)
Change in luminal diameter post nitro (FMD nitro, mm) 0.13±0.04 (5) 0.29±0.04 (6) a
Vascular dilatation post nitro (FMD nitro %) 6.7±2.1 (5) 11.2±1.4 (6)
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indicated in Table 1. With this number of observations per
trait, respectively 120, 720, or 5040 unique permutations are
possible. Therefore, the level of significance of the original
correlation may have been overestimated. For this reason,
bootstrapping was performed on all traits in order to increase
the number of unique combinations beyond 10,000 in order to
improve the estimation of the level of significance of correla-
tions between traits.
Table 3 illustrates co-segregation of traits for lean and
obese minipigs following bootstrapping. Functional co-
segregation networks of traits for lean and obese minipigs
are visualised in Fig. 1. The parameters with the most signif-
icant level of co-segregation following permutation test are,
amongst others, those that are dependent or derived from each
other, for example NONFAT% and FAT%, INS and QUICKI,
Asc and VitC or similar parameters measured using different
methods, e.g. MASS and BW (Table 2). These results can be
Table 2 Co-segregation of traits in lean and obese minipigs according to
the level of significance following permutation test
Lean minipigs Obese minipigs
Co-segregation of traits at p<0.001
MASS BW 0.983 MASS BW 0.997
FAT NONFAT % −0.965 NONFAT % FAT % −1.000
FAT FAT % 0.965 Asc VitC 0.968
NONFAT % FAT % −1.000
INS QUICKI −0.937
Co-segregation of traits at p<0.005
LDL TG 0.985 LDL CHOL 0.928
CHOL WTh −0.973 FMD % W/L 0.997
Asc VitC 0.953 BH2/4 % DHA 0.801
Co-segregation of traits at p<0.01
FAT MASS 0.916 FAT MASS 0.898
HW FVI delta 0.963 NONFAT MASS 0.904
FMD FMD % 0.991 FAT BW 0.886
BW GLUC 0.894 NONFAT BW 0.910
FMD BH2 0.893 INS C-Pep 0.944
FMD % BH2 0.869 pD2 SP QUICKI 0.956
FMD % PAGP 0.930 INS QUICKI −0.901
BH4 PAGP 0.902 FVI delta % DHA −0.886
Co-segregation of traits at p<0.05
NONFAT MASS 0.850 NONFAT FRUC 0.818
FAT BW 0.874 MASS FRUC 0.780
NONFAT BW 0.865 BMC pD2 NIF 0.899
MASS NONFAT% −0.782 Do HW 0.916
MASS FAT% 0.782 TG FVI delta −0.745
NONFAT CHOL 0.915 pD2 NIF FVI delta −0.855
MASS CHOL 0.877 Do FMD 0.905
BW CHOL 0.852 FMD FMD % 0.958
LDL CHOL 0.850 LDL FMD nitro −0.784
Do K
+ max 0.894 CHOL FMD nitro −0.854
K+ max U46619 0.882 LDL FMD nitro
%
−0.793
NONFAT pD2 NIF −0.831 CHOL FMD nitro
%
−0.900
MASS pD2 NIF −0.893 K+ max FMD nitro
%
0.959
BW pD2 NIF −0.891 pD2 SP INS −0.890
CHOL pD2 NIF −0.917 FMD nitro
%
WTh 0.962
U46619 HW 0.902 QUICKI WTh −0.871
pD2 BRAD FMD 0.990 K
+ max W/L 0.946
pD2 BRAD FMD % 0.982 TG BH2 0.744
FAT GLUC 0.775 FVI delta BH2 −0.926
NONFAT GLUC 0.774 FVI delta BH2/4 −0.971
MASS GLUC 0.880 C-Pep BH2/4 0.762
pD2 NIF GLUC −0.958 BH2 BH2/4 0.913
Do INS 0.799 BH4 BH2/4 −0.792
K+ max vessel D −0.918 TG Asc −0.819
INS vessel D −0.941 BH2/4 Asc −0.670
QUICKI vessel D 0.859 TG % DHA 0.851
Table 2 (continued)
Lean minipigs Obese minipigs
INS Lumen −0.910 C-Pep % DHA 0.867
vessel D Lumen 0.983 BH2 % DHA 0.816
MASS WTh −0.859 Asc % DHA −0.880
BW WTh −0.909 pD2 SP PAGP 0.876
LDL WTh −0.919 pD2 NIF Hp −0.871
pD2 NIF WTh 0.887 GLUC Hp 0.858
GLUC WTh −0.799 K+ max CRP 0.952
pD2 NIF W/L 0.909 FMD nitro
%
CRP 0.974
Vessel D W/L −0.894 Hp CRP 0.856
Lumen W/L −0.951 LDL SAA 0.774
pD2 BRAD BH2 0.884 FVI % SAA 0.837
C-Pep BH2 0.768
pD2 BRAD BH4 0.896
FMD BH4 0.808
FMD % BH4 0.827
FVI % Asc 0.964
Do VitC 0.844
HW VitC 0.837
FVI % VitC 0.950
FAT PAGP −0.798
NONFAT
%
PAGP 0.842
FAT % PAGP −0.842
pD2 BRAD PAGP 0.933
FMD PAGP 0.936
BH4 CRP −0.913
BH2/4 CRP 0.868
BH2/4 SAA 0.871
CRP SAA 0.891
Shown are pairs of traits and their respective correlation coefficient. Italics
indicate co-segregations occurring both in lean and obese animals
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seen as a performance validation of the analysis method.
Although some co-segregation between traits are present in
lean as well as obese animals, many co-segregations that can
be identified in the lean are not present in the obese or vice
versa. Bootstrapping resulted in loss of co-segregations that
were present following permutation test alone, as expected
(Tables 2 and 3, Fig. 1). Although HW, Do and BW are
significantly different between groups on an average basis
(Table 1), HWand Do appear to co-segregate only in the obese
(Table 3 and Fig. 1).
Discussion
Well characterized animal models of disease are a prerequisite
for unravelling of disease mechanisms, in particular for pre-
dictive validity of findings obtained in animals, for example
efficacy of novel therapeutics and their translatability into
clinically meaningful biomarkers or endpoints. It is becoming
more and more evident that measurement of few biomarkers
or endpoints in an animal model is far from sufficient to
reliably predict disease progression or efficacy and safety of
pharmacotherapy in humans. The clinical presentation of obe-
sity is not merely restricted to bodymass index, but to a certain
pattern of changed phenotypical traits associated with the
condition, such as impaired glucose tolerance, dyslipidaemia,
inflammation, altered glucose and insulin levels or an appar-
ent state of redox imbalance [7]. Individually, these traits do
not necessarily differ from a normal range but in concert, they
may show a deviating pattern as compared to a ‘normal’
healthy human phenotype. This means that the state of a
disease, be it obesity, can usually not be defined as a crisp
normal or diseased, but rather as a continuum of changes in
various phenotypical traits, with a certain degree of deviation
from the normal distribution.
The consequence of a solely hypothesis-driven approach is
that, in order to be able to observe significant effects of any
novel therapeutic towards normalising disease markers, or at
least as compared to untreated controls, one needs an animal
model showing statistically significant differences in disease-
dependent key phenotypical traits. In other words, a
Table 3 Co-segregation of traits in lean and obese minipigs according to
the level of significance following bootstrapping
Lean minipigs Obese minipigs
Cosegregation of traits at p<0.001
NONFAT % FAT % −1.000 MASS BW 0.997
NONFAT % FAT % −1.000
Cosegregation of traits at p<0.005
MASS BW 0.983
FAT NONFAT % −0.965
FAT FAT % 0.965
Asc VitC 0.953
Cosegregation of traits at p<0.01
FAT MASS 0.916 FAT MASS 0.898
BW GLUC 0.894 NONFAT MASS 0.904
INS QUICKI −0.937 FAT BW 0.886
BH4 PAGP 0.902 NONFAT BW 0.910
LDL CHOL 0.928
INS QUICKI −0.901
Asc VitC 0.968
Cosegregation of traits at p<0.05
NONFAT MASS 0.850 NONFAT FRUC 0.818
FAT BW 0.874 MASS FRUC 0.780
NONFAT BW 0.865 BMC pD2 NIF 0.899
MASS NONFAT % −0.782 Do HW 0.916
MASS FAT % 0.782 CHOL FMD nitro % −0.900
LDL TG 0.985 pD2 SP INS −0.890
NONFAT CHOL 0.915 INS C-Pep 0.944
MASS CHOL 0.877 pD2 SP QUICKI 0.956
BW CHOL 0.852 TG BH2 0.744
MASS pD2 NIF −0.893 FVI BH2 −0.926
BW pD2 NIF −0.891 FVI BH2/4 −0.971
U46619 HW 0.902 BH2 BH2/4 0.913
FMD FMD % 0.991 BH4 BH2/4 −0.792
FAT GLUC 0.775 TG Asc −0.819
NONFAT GLUC 0.774 TG % DHA 0.851
MASS GLUC 0.880 FVI % DHA −0.886
pD2 NIF GLUC −0.958 C-Pep % DHA 0.867
INS vessel D −0.941 BH2 % DHA 0.816
INS Lumen −0.910 BH2/4 % DHA 0.801
MASS WTh −0.859 Asc % DHA −0.880
BW WTh −0.909 pD2 SP PAGP 0.876
CHOL WTh −0.973 pD2 NIF Hp −0.871
INS W/L 0.865 GLUC Hp 0.858
FMD BH2 0.893 Hp CRP 0.856
FMD % BH2 0.869
C-Pep BH2 0.768
BH4 BH2/4 −0.782
Do VitC 0.844
HW VitC 0.837
FAT PAGP −0.798
NONFAT % PAGP 0.842
Table 3 (continued)
Lean minipigs Obese minipigs
FAT % PAGP −0.842
FMD PAGP 0.936
FMD % PAGP 0.930
BH4 CRP −0.913
BH2/4 CRP 0.868
Shown are pairs of traits and their respective correlation coefficient. Italics
indicate co-segregation occurring both in lean and obese animals
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hypothesis-driven approach requires an animal model of dis-
ease, in which the parameters of interest are often beyond the
usual auto-regulatory homeostatic capacity of the biological
system, in order for them to become sufficiently different from
healthy subjects. This implies that subjects with borderline
changes of disease-dependent phenotypical traits are avoided
in animal studies evaluating efficacy of novel therapeutics,
whereas extreme changes in traits are preferred in order to
increase the probability of observing significant treatment
effects. Evidently, this does not translate well to the general
overweight population, but perhaps to the obese or morbidly
obese population, which account for only a minority of the
total population with increased BW.
To illustrate this dilemma, we have shown that in obese
minipigs, although they weighed about twice as much as their
lean controls and had a significantly higher body fat percent-
age, their lipid profile, reflected by CHOL, TG and LDL, only
tended to be increased, without reaching statistical signifi-
cance, when compared on an individual parameter basis. Insu-
lin sensitivity, reflected by QUICKI index, was apparently
higher in the obese than in the lean, and none of the markers
for oxidative stress or inflammation were significantly differ-
ent between lean and obese animals. Also, the most pro-
nounced intimal thickening was found in the lean group and
no significant difference was found between the groups. Pe-
ripheral vascular function showed a relative increased reactive
hyperaemic response following cuff occlusion in obese com-
pared to lean animals, but also in response to nitroglycerin,
whereas coronary artery sensitivity for the dilating effect of
substance P was lower, and for the calcium channel blocker
nifedipine was significantly higher in obese as compared to
lean. This apparent contradiction between vascular and endo-
thelial function in different vascular beds and between lean and
obese subjects has previously been shown in animal and
human studies and maybe indicative of compensatory mecha-
nisms in response to altered endothelial function or an altered
physiological reserve in the obese [6, 1]. Thus, in general, a
number of parameters usually associated with obesity were not
significantly different between obese and lean animals. This
may be due to insufficient statistical power and furthermore,
obvious differences in weight and size could have affected
FMD and some of the metabolic parameters differently. In
addition, the lack of any major metabolic differences between
the two groups could be related to the fact that both groups
were fed a normal low-fat pig chow albeit at different levels,
whereas in humans, obesity is often related to the intake of
high fat, high sugar dietary items, which may by themselves
affect the metabolic parameters independent of obesity.
Nevertheless, the usefulness of many of the phenotypical
traits used in disease state assessment, or effect of pharmaco-
logical intervention, may be questionable because of the ap-
parent lack of difference between the obese and the lean
Göttingen minipigs.
To address this problem, we utilised a correlation matrix of
phenotypical traits and assessed co-segregations between all
traits using either permutation with or without bootstrapping.
These were used in order to assess the strength of co-
segregation between traits, which is of particular importance
given the low number of observations in both groups of
Fig. 1 Functional networks of traits for lean (a) or obese (b) minipigs
following bootstrapping. All traits are represented as nodes, whereas
significant co-segregations are indicated by connections between nodes,
also indicating correlation coefficient. The thickness of the edges is
proportional to the significance of the correlation, i.e. the thickest lines
indicate significance of co-segregation with p<0.001, whereas the thin-
nest lines indicate significance at p <0.05. Trait abbreviations are ex-
plained in the text and Table 1. Placement of traits is not identical between
lean and obese animals, but is based on shortest distance between nodes
with edges according to Gephi Force Atlas
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animals. Additionally, no prior assumptions were made as to
whether co-segregation of traits was causatively related or not.
Dependency of traits, in fact, served as a validation of the
method, in that dependent variables would be expected to co-
segregate. This was also shown to be the case, since BW and
mass, mass versus fat and non-fat mass, total VitC and Asc,
plasma insulin and QUICKI, CHOL and LDL and BH4 and
BH2/4 ratio correlated with a high level of significance in both
lean and obese animals. On the other hand, significant co-
segregations were revealed in the lean network that originally
may not have been expected, such as plasma insulin and
coronary artery diameter, C-peptide and BH2, cholesterol
and coronary artery wall thickness, or of Pig α1-acid glyco-
protein (PAGP) versus BH4, fat, fat percentage, non-fat per-
centage, glucose or peripheral reactive hyperaemia (FMD),
respectively. Interestingly, a recent report on the serum con-
centration of PAGP in obese minipigs showed that in some pig
breeds (Ossabaw pigs) but not in Göttingen minipigs, PAGP
serum concentrations were indeed significantly increased in
obese as opposed to lean pigs [20]. Contrary to this, correla-
tions that may have been expected appeared to be non-
significant following bootstrapping. For example, HDL,
SAA, FMD and FVI did not appear to co-segregate with any
other trait, in either the lean or the obese network, which might
suggest that these phenotypical traits are not likely to be
predictive for any change in the system under the obese
condition in the present experimental setup.
Overall, nine co-segregations of traits were common be-
tween lean and obese animals (indicated by italics in Table 3),
although their level of significance may, on occasions, be
different between lean and obese animals. These co-
segregations comprised the dependent relations mentioned
above. However, much co-segregation present in the lean
network had disappeared in the obese network, whereas
others, not present in the lean network, appeared in the obese.
From a drug development point of view, such relations may be
of considerable interest, since they distinguish the obese from
the lean state, and may be used in an exploratory way to assess
whether pharmacotherapy can reverse the obesity dependent
co-segregations towards the lean-dependent co-segregations.
Most notably, for example, is the absence of any relation of
%DHA, haptoglobin or FVI with any other trait in the lean,
and the appearance of six co-segregations of %DHA, and
three relations between haptoglobin and FVI with other traits
in the obese, respectively. This would indicate the presence of
an oxidative and inflammatory environment in the obese that
is not evident in the lean, since the acute phase protein hapto-
globin co-segregates with the acute phase protein CRP, blood
glucose levels and nifedipine sensitivity and FVI associates
with markers of oxidative stress (BH2 and BH2/4) in the
obese but not in the lean; both inflammation and oxidative
stress have been described as part of the obesity response as
previously suggested [22, 13]. Indeed, only in obese animals
%DHA co-segregates positively with BH2/BH4, BH2 and
TG, and negatively with FVI, indicative of an oxidative envi-
ronment in these animals. This agrees well with the work of
Furukawa and coworkers, who found that increased oxidation
in accumulated fat is an important pathogenic mechanism of
obesity-associated metabolic syndrome through systemic ox-
idative stress and inflammation [7]. In principle, by measuring
but a few values for one or few traits, the networks could be
used to estimate values of other traits, using the correlation
coefficients and respective confidence intervals between traits,
hereby predicting changes in traits, for example following
treatment or other interventions to the system. Furthermore,
the present minipig networks should be compared to a similar
functional network obtained in other animal models of obesi-
ty, or most importantly, with a functional network of similar
traits obtained in healthy or obese patients. This is expected to
strengthen the translation of the animal model towards the
clinical situation dramatically. After all, high-level phenotyp-
ical data are common in a clinical setting. Currently, integra-
tion of these data is done by experts, but this process could be
aided by construction of functional networks as illustrated in
the present study.
However, the validity of a network is crucial for the power
of any predictions based on that network. In the present case,
the number of animals and observations is low, and although
bootstrapping or permutation might solve this problem, it
cannot be excluded that adding data for a single animal could
influence the network topology significantly. Additionally, a
high precision and accuracy of the measurements of traits is
very important. To illustrate this, many values for serum
amyloid A protein (SAA) were below the lowest level of
quantification (LOQ) of the assay, implying that the distribu-
tion of values for the group were skewed towards the LOQ,
and thus not normally distributed. In addition to assay specific
issues, biological system-specific issues could result in
skewed data. For example, traits may behave linearly within
a physiological range, until the system is stressed and traits
reach their physiological auto-regulatory limits. Furthermore,
other system corrective or compensatory mechanisms modify,
mask or overrule the trait of interest, resulting in non-linear,
unexpected behaviour. Another issue that might be of impor-
tance for the validity of the network is the conditions under
which samples or measurements of traits were taken. This,
however, is not a network-specific issue, but is of crucial
importance for any scientific approach or comparison.
Finally, significant correlations between traits could be
non-linear. These events could obviously affect the va-
lidity of the network, and caution should therefore be
taken.
In conclusion, the present results show that in a phenotyp-
ically obese group of minipigs, many obesity related param-
eters were not statistically different from lean animals on an
individual comparative basis. However, when visualised as a
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functional network of co-segregations, marked differences
between lean and obese animals appeared that could be
utilised to better assess the effect of anti-obesity treatment or
to evaluate disease progression. Functional network analysis
may therefore offer a better understanding of changes in
physiological system processes and could lead to a better
prediction of clinical outcome of novel therapeutics using
relatively small numbers of individuals. Furthermore, the
functional network can perhaps form the basis of a transla-
tional tool that connects obese minipigs patho-physiological
processes to those of human obese patients.
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